Clinical Trial Update: Effectiveness of Cannabinoids on Appetite in Scleroderma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated cannabinoids for improving appetite in individuals with systemic sclerosis and related malnutrition, and the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malnutrition
• Systemic Sclerosis

Drugs mentioned

• Cannabinoids (cannabinoids)

Snippet

Sponsor: Khon Kaen University | Conditions: Systemic Sclerosis, Malnutrition | Phase 3 | Status: COMPLETED